NCT00711061

Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 24 (actual)
• Sponsor: Children's Mercy Hospital Kansas City · Academic / Other
• Sex: Male
• Age: 18 Years – 25 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the cardiovascular risks of growth hormone deficient young adult males who have completed growth hormone therapy to healthy young adult males.

Detailed description

Adults with growth hormone deficiency are at risk for cardiovascular disease. What age this begins is not known. The objectives of this study are to compare the following measurements between growth hormone deficient young males 3-7 years post completion of growth hormone treatment and age related healthy controls: 1. Carotid artery imaging 2. Metabolic and cardiac parameters 3. Body composition measurements

Conditions

• Growth Hormone Deficiency

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-02-01
• Completion: 2009-02-01
• First posted: 2008-07-08
• Last updated: 2009-02-10

Locations

1 site across 1 country: United States